Appello Pharmaceuticals

Nashville, United States

Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.

$13.5M raised

Jan 2022

Series B

Biotechnology Health Care Pharmaceutical

Top Investors

Deerfield Mountain Group Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Appello Pharmaceuticals

How much funding has Appello Pharmaceuticals raised?

Appello Pharmaceuticals has raised $13.5M in total funding. The most recent round was Series B. The last funding was announced in January 2022.

Who are Appello Pharmaceuticals's investors?

Appello Pharmaceuticals's investors include Deerfield, Mountain Group Capital.

Where is Appello Pharmaceuticals headquartered?

Appello Pharmaceuticals is headquartered in Nashville, United States.

What does Appello Pharmaceuticals do?

Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.

What stage is Appello Pharmaceuticals at?

Appello Pharmaceuticals is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 24, 2022.

MLA

"Appello Pharmaceuticals — Funding & Investors." VCBacked, January 24, 2022, https://www.vcbacked.co/company/appello-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2022). Appello Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/appello-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Appello Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/appello-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 24, 2022.